Cardiovascular Toxicity and Immune Checkpoint Inhibitors

Immune checkpoints are integral to the immune system, ensuring that there is no overactivation once an immune response is triggered. Seven immune checkpoint inhibitors — which interfere with that natural brake in the immune system — are currently approved for use in cancer treatment. The immune checkpoint inhibitors unleash T cells to attack a tumor, with dramatic results.